Mechanism of cyclooxygenase-2 upregulation in late preconditioning

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 5, 2003, Pages 525-537

  Xuan, Yu Ting ^a   Guo, Yiru ^a   Zhu, Yanqing ^a   Han, Hui ^a   Langenbach, Robert ^a   Dawn, Buddhadeb ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

COX 2; INOS ; Ischemia; Myocardial infarction; Prostaglandin; STAT proteins

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTIBODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA BINDING PROTEIN; ENZYME INHIBITOR; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NITRIC OXIDE SYNTHASE; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; GENE TARGETING; HEART INFARCTION PREVENTION; HEART MUSCLE REPERFUSION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

JANUS;

EID: 0013126850     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00076-2     Document Type: Article

References (48)

1. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299.
2. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
3. Sun J.Z., Tang X.L., Park S.W., Qiu Y., Turrens J.F., Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 97:1996;562-576.
4. Bolli R., Manchikalapudi S., Tang X.L., Takano H., Qiu Y., Guo Y., et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res. 81:1997;1094-1107.
5. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997;42-52.
6. Qiu Y., Ping P., Tang X.L., Manchikalapudi S., Rizvi A., Zhang J., et al. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ε is the isoform involved. J Clin Invest. 101:1998;2182-2198.
7. Dawn B., Xuan Y.T., Qiu Y., Takano H., Tang X.L., Ping P., et al. Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res. 85:1999;1154-1163.
8. Jones W.K., Flaherty M.P., Tang X.L., Takano H., Qiu Y., Banerjee S., et al. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism. J Mol Cell Cardiol. 31:1999;1469-1481.
9. Ping P., Zhang J., Zheng Y.T., Li R.C., Dawn B., Tang X.L., et al. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res. 85:1999;542-550.
10. Xuan Y.T., Tang X.L., Banerjee S., Takano H., Li R.C., Han H., et al. Nuclear factor-KB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 84:1999;1095-1109.
11. Shinmura K., Tang X.L., Wang Y., Xuan Y.T., Liu S.Q., Takano H., et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 97:2000;10197-10202.
12. Guo Y., Bao W., Wu W.J., Shinmura K., Tang X.L., Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol. 95:2000;479-484.
13. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983.
14. Xuan Y.T., Tang X.L., Qiu Y., Banerjee S., Takano H., Han H., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol. 279:2000;H2360-2371.
15. Shinmura K., Xuan Y.T., Tang X.L., Kodani E., Han H., Zhu Y., et al. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res. 90:2002;602-608.
16. Xuan Y.T., Yiru G., Hui H., Yanqing Z., Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 98:2001;9050-9055.
17. Guo Y., Jones W.K., Xuan Y.T., Bao W., Wu W.J., Han H., et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the iNOS gene. Proc Natl Acad Sci USA. 96:1999;11507-11512.
18. Appleby S.B., Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J. 302:1994;723-727.
19. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 270:1995;31315-31320.
20. Kim Y., Fischer S.M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem. 273:1998;27686-27694.
21. Yamaoka K., Otsuka T., Niiro H., Nakashima H., Tanaka Y., Nagano S., et al. Selective DNA-binding activity of interleukin-10-stimulated STAT molecules in human monocytes. J Interferon Cytokine Res. 19:1999;679-685.
22. Horvath C.M., Wen Z., Darnell J.E. A Stat protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Gene Dev. 9:1995;984-994.
23. Decker T., Kovarik P., Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res. 17:1997;121-134.
24. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1993;7240-7244.
25. Salvemini D., Seibert K., Masferrer J.L., Misko T.P., Currie M.G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 93:1994;1940-1947.
26. Davidge S.T., Baker P.N., Laughlin M.K., Roberts J.M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 77:1995;274-283.
27. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA. 95:1998;10966-10971.
28. Marnett L.J., Wright T.L., Crews B.C., Tannenbaum S.R., Morrow J.D. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem. 275:2000;13427-13430.
29. Stadler J., Harbrecht B.G., Di Silvio M., Curran R.D., Jordan M.L., Simmons R.L., et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol. 53:1993;165-172.
30. Amin A.R., Attur M., Patel R.N., Thakker G.D., Marshall P.J., Rediske J., et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide. J Clin Invest. 99:1997;1231-1237.
31. Habib A., Bernard C., Lebret M., Creminon C., Esposito B., Tedgui A., et al. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol. 158:1997;3845-3851.
32. 2 production by nitric oxide in activated murine macrophages. J Immunol. 162:1999;4191-4197.
33. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol. 165:2000;1582-1587.
34. Tsai A.L., Wei C., Kulmacz R.J. Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys. 313:1994;367-372.
35. Curtis J.F., Reddy N.G., Mason R.P., Kalyanaraman B., Eling T.E. Nitric oxide: a prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages. Arch Biochem Biophys. 335:1996;369-376.
36. Hamilton L.C., Warner T.D. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib. Br J Pharmacol. 125:1998;335-340.
37. Hoving S., Bar-Shimon M., Tijmes J.J., Goldshleger R., Tal D.M., Karlish S.J. Novel aromatic isothiouronium derivatives which act as high affinity competitive antagonists of alkali metal cations on Na/K-ATPase. J Biol Chem. 270:1995;29788-29793.
38. Southan G.J., Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 51:1996;383-394.
39. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 272:1997;4959-4963.
40. Guo Y., Wu W.J., Qiu Y., Tang X.L., Yang Z., Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 275:1998;H1375-1387.
41. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
42. Singh K., Balligand J.L., Fischer T.A., Smith T.W., Kelly R.A. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem. 271:1996;1111-1117.
43. Xie Q., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
44. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 416:2002;337-340.
45. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:1998;97-120.
46. Adderley S.R., Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem. 274:1999;5038-5046.
47. Schmedtje Jr J.F., Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 272:1997;601-608.
48. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension. 31:1998;218-224.